Patents

Method for Wild Camomile Flowers Identification

The invention relates to pharmacognostic analysis and, namely, to identification of wild chamomile flowers. The method involves analysis of solutions containing an alcohol extract of wild chamomile flowers and pierced mayweed flowers, a complexing substance and a buffer solution with Ph equal to 4-5, by spectrophotometric method at a wavelength of 340±2 nm and a maximum absorption at the specified wavelength on the absorption spectrum of the flowers extract identifies pierced mayweed flowers, and the absence of the maximum absorption at the specified wavelength on the absorption spectrum of the flowers identifies wild chamomile flowers. The method simplifies process of herbal medicinal raw materials (wild chamomile flowers) authentication. 1 dependent claim, 1 drawing.

Velikhanova Zaira Anna Marakhova Sorokina Alla Yaroslav Stanishevsky Boris Shvitko

Method of complex extraction of biologically active substances from medicinal plant materials at the cellular level

The invention pertains to medicine, more specifically, to pharmacognosy and pharmacy. The use of the invention makes it possible to increase the yield of biologically active substances from a medicinal plant substance.

Ya.M.Stanishevsky L.F.Sahibgarayeva I.A.Shvitko Anna Marakhova

Method for extracting essential oil from medicinal plant materials

The invention pertains to the pharmaceutical industry, more specifically to a method for extracting essential oil from medicinal plant materials. The method makes it possible to purify the essential oil from the medicinal plant materials as a separate phase over water, which facilitates its collection in pure form and substantially increases the extraction efficiency comparing to hydrodistillation.

Ya.M.Stanishevsky L.F.Sahibgarayeva I.A.Shvitko V.Yu.Zhilkina

Producer of mycoplasma inhibitor (Mycoplasma hominis)

The invention pertains to medicine, biochemistry and pharmacology and can be used in biotechnology, microbiology. It is aimed at suppressing the growth of Mycoplasma hominis. To do this, the strain Trichoderma harzianum Rifai F-180 is used as an inhibitor of Mycoplasma hominis.

I.P.Smirnova I.V.Rakovskaya

Capsule for the pharmacologic composition

This utility model pertains to the field of pharmacological agents, more specifically to a capsule of a pharmacological preparation and similar small volume vessels for oral pharmacological administration, with a cavity for placing a liquid pharmacological composition. The technical result of the utility model is the length of the retention period of the active component.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Suppository configuration

The utility model belongs to the field of medicine, more specifically to the forms of medicinal, immunomodulating drugs. The technical result of the present utility model is the combination of high immunomodulating activity with a more effective design of the suppository form for inserting and fixing it into the body cavity. The claimed technical result is achieved by the fact that the device of the suppository, consisting of active and auxiliary substances, is made monolithically.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov